PALISADE BIO, INC. (PALI) › Operating Cash FlowPALISADE BIO, INC. (PALI) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2009: -$5.14M2010: -$9.98M2011: -$8.10M2012: -$8.48M2016: -$15.62M2017: -$13.42M2018: -$7.69M2019: -$7.26M2020: -$4.77M2021: -$14.77M2022: -$13.36M2023: -$11.13M2024: -$12.19M2025: -$10.85M-$10.85M2009Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$10.85M+11.0%2024-$12.19M-9.5%2023-$11.13M+16.7%2022-$13.36M+9.6%2021-$14.77M-209.8%2020-$4.77M+34.3%2019-$7.26M+5.7%2018-$7.69M+42.7%2017-$13.42M+14.1%2016-$15.62M—2012-$8.48M-4.7%2011-$8.10M+18.9%2010-$9.98M-94.0%2009-$5.14M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share